Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0286 -0.0015 (-4.98%) 04/23/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0286 unch (unch) 15:55 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0275
Day High
0.0339
Open 0.0294
Previous Close 0.0301 0.0301
Volume 720,600 720,600
Avg Vol 446,830 446,830
Stochastic %K 24.94% 24.94%
Weighted Alpha -64.82 -64.82
5-Day Change -0.0079 (-21.64%) -0.0079 (-21.64%)
52-Week Range 0.0245 - 0.0629 0.0245 - 0.0629
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0245 +16.73%
on 04/21/25
Period Open: 0.0384
0.0432 -33.80%
on 03/31/25
-0.0098 (-25.52%)
since 03/21/25
3-Month
0.0245 +16.73%
on 04/21/25
Period Open: 0.0417
0.0467 -38.76%
on 01/31/25
-0.0131 (-31.41%)
since 01/23/25
52-Week
0.0245 +16.73%
on 04/21/25
Period Open: 0.0617
0.0629 -54.53%
on 04/24/24
-0.0331 (-53.65%)
since 04/23/24

Most Recent Stories

More News
Zoonotic Threats, Invasive Species, and Food Chain Shocks: Why Animal Biotech Is on Watchlists Now

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – Baystreet.ca News Commentary – Animal health...

BVAXF : 0.0286 (-4.98%)
ELAN : 9.19 (+3.37%)
BIOV.CN : 0.0400 (unch)
ZTS : 150.91 (+0.61%)
NEOG : 4.92 (+3.58%)
SNES : 1.8100 (-5.73%)
BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce an...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
BioVaxys Technology Corp. Granted Management Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that, further to its news release dated February...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
BioVaxys Announces Application for Management Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in the completion of...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
How Advanced Drug Delivery is Revolutionizing Global Healthcare in 2025

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – How we deal with future spikes in disease cases and potential global pandemics is evolving rapidly. Not only is the...

BVAXF : 0.0286 (-4.98%)
SVRA : 3.25 (+0.93%)
BIOV.CN : 0.0400 (unch)
TMO : 431.64 (-0.71%)
VERV : 5.47 (+4.19%)
AQST : 2.82 (+2.55%)
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential for its DPXâ„¢ non-systemic...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical-stage company developing a portfolio of...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 33.16 (+6.08%)
BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
GILD : 106.38 (+0.82%)
GOVX : 0.8480 (+3.68%)
ARCT : 12.65 (+3.94%)
BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that in anticipation of...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
BioVaxys Shares New Data on its DPXâ„¢ Immune Educating Platform at Personalized Cancer Vaccine Summit

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at the Personalized Cancer...

BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)

Key Turning Points

3rd Resistance Point 0.0389
2nd Resistance Point 0.0364
1st Resistance Point 0.0325
Last Price 0.0286
1st Support Level 0.0261
2nd Support Level 0.0236
3rd Support Level 0.0197

See More

52-Week High 0.0629
Fibonacci 61.8% 0.0482
Fibonacci 50% 0.0437
Fibonacci 38.2% 0.0392
Last Price 0.0286
52-Week Low 0.0245

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective